|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-4-14
|
|
pubmed:abstractText |
Ciprofloxacin can inhibit the cytochrome P450-mediated metabolism of theophylline, but the clinical relevance of this drug interaction is uncertain. We studied the risk of theophylline toxicity associated with the co-prescription of ciprofloxacin and theophylline.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1432-1041
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
521-6
|
|
pubmed:meshHeading |
pubmed-meshheading:21234553-Aged,
pubmed-meshheading:21234553-Aged, 80 and over,
pubmed-meshheading:21234553-Case-Control Studies,
pubmed-meshheading:21234553-Ciprofloxacin,
pubmed-meshheading:21234553-Drug Interactions,
pubmed-meshheading:21234553-Female,
pubmed-meshheading:21234553-Humans,
pubmed-meshheading:21234553-Male,
pubmed-meshheading:21234553-Ontario,
pubmed-meshheading:21234553-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:21234553-Theophylline
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Ciprofloxacin-induced theophylline toxicity: a population-based study.
|
|
pubmed:affiliation |
University of Toronto, Toronto, ON, Canada. tantoniou@smh.toronto.on.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
